patient
methodsw
review
medic
record
children
nasal
wash
cultur
posit
piv
institut
nasal
wash
sampl
assay
inflammatori
mediat
use
luminex
bead
proteom
patient
age
week
year
singl
viru
infect
includ
final
analysi
patient
infect
lrti
diagnos
patient
ltb
uri
ltb
lrti
diagnos
patient
infect
infect
compar
uninfect
control
patient
pivinfect
patient
higher
nasal
wash
concentr
interleukin
il
macrophag
inflammatori
protein
mip
monokin
induc
interferon
gamma
mig
regul
upon
activ
normal
cell
express
secret
rant
patient
lrti
moder
sever
ill
respiroviru
infect
piv
higher
nasal
wash
concentr
compar
patient
uri
mild
ill
rubulaviru
infect
piv
p
conclusionspiv
infect
caus
spectrum
ill
associ
express
releas
sever
proinflammatori
mediat
note
elev
level
nasal
wash
sampl
associ
sever
form
piv
diseas
parainfluenza
virus
piv
respons
third
acut
respiratori
tract
infect
infant
children
primari
piv
infect
symptomat
reinfect
milder
continu
occur
age
clinic
spectrum
ill
caus
piv
includ
upper
uri
lower
respiratori
tract
infect
lrti
encompass
rhinosinus
otiti
media
pharyng
laryngotracheobronch
ltb
bronchiol
pneumonia
group
piv
among
common
caus
lower
respiratori
tract
infect
young
children
account
acut
lower
respiratori
tract
ill
viru
recover
piv
account
second
largest
number
pediatr
hospit
communityacquir
respiratori
ill
second
respiratori
syncyti
viru
account
almost
hospit
fever
andor
acut
respiratori
ill
young
children
four
human
parainfluenza
virus
recogn
type
divid
two
genera
base
upon
complement
fixat
hemagglutin
antigen
genu
respiroviru
includ
piv
type
genu
rubulaviru
includ
piv
type
piv
lead
caus
ltb
children
piv
frequent
associ
lrti
includ
bronchiol
pneumonia
season
pattern
human
piv
infect
differ
accord
viru
type
piv
preval
late
spring
summer
piv
occur
commonli
late
fall
earli
winter
outbreak
piv
infect
usual
follow
piv
outbreak
piv
infect
continu
throughout
year
primarili
spring
summer
piv
isol
infrequ
seroepidemiolog
studi
indic
approxim
half
us
children
older
one
year
nearli
five
year
age
infect
piv
antibodi
piv
develop
somewhat
later
children
demonstr
seroposit
age
five
year
although
infect
less
commonli
identifi
cultur
young
adult
seroposit
piv
pathophysiolog
piv
infect
gener
accept
result
direct
viru
cytotox
accompani
robust
virusinduc
inflammatori
respons
infect
airway
initi
host
respons
infect
dictat
event
occur
within
infect
respiratori
epitheli
cell
proinflammatori
mediat
releas
infect
cell
direct
recruit
inflammatori
cell
site
infect
contribut
clinic
manifest
diseas
previous
demonstr
epitheli
cell
line
explant
human
bronchial
epitheli
cell
respond
piv
infect
product
releas
proinflammatori
chemokin
macrophag
inflammatori
protein
interestingli
local
product
proinflammatori
mediat
respons
rsv
infect
document
extens
analog
publish
studi
evalu
inflamm
respons
piv
studi
describ
clinic
manifest
piv
children
identifi
differ
present
sever
accord
piv
type
document
proinflammatori
mediat
fingerprint
detect
nasal
wash
sampl
obtain
patient
nasal
wash
sampl
obtain
children
evalu
emerg
room
suspect
respiratori
viral
infect
archiv
laboratori
sinc
protocol
approv
suni
upstat
medic
univers
irbph
children
includ
present
studi
evalu
suspect
acut
respiratori
viral
infect
nasal
wash
sampl
collect
cultur
posit
piv
nasal
wash
sampl
residu
nasal
wash
sampl
avail
character
identifi
patient
chart
review
perform
collect
patient
inform
includ
demograph
detail
regard
clinic
present
inform
whether
patient
hospit
detail
regard
hospit
cours
three
categori
ill
sever
use
purpos
studi
mild
moder
sever
mild
diseas
defin
ill
requir
hospit
moder
diseas
ill
requir
hospit
requir
administr
supplement
oxygen
sever
diseas
defin
ill
requir
hospit
treatment
supplement
oxygen
andor
admiss
pediatr
intens
care
unit
addit
obtain
inform
consent
nasal
wash
sampl
asymptomat
children
age
two
week
year
obtain
use
control
age
gender
distribut
control
group
similar
research
subject
children
age
one
year
children
age
one
four
year
fortyfour
control
subject
male
nucleic
acid
extract
archiv
nasal
wash
sampl
piv
cultur
posit
patient
asymptomat
control
patient
nucleic
acid
subject
amplif
luminex
respiratori
viru
panel
rvp
determin
whether
patient
infect
coinfect
enteroviru
rhinoviru
human
metapneumoviru
rsv
b
coronaviru
adenoviru
parainfluenza
influenza
b
twelv
sampl
document
cultur
posit
rvp
posit
virus
piv
patient
exclud
analysi
possibl
determin
infect
virus
contribut
clinic
present
pattern
induc
proinflammatori
mediat
none
patient
examin
simultan
infect
one
piv
type
cytokin
profil
determin
nasal
wash
fluid
use
human
cytokin
twenti
sixplex
bead
immunoassay
kit
design
detect
interleukin
il
interferon
inf
granulocyt
macrophag
coloni
stimul
factor
macrophag
chemotact
protein
mcp
macrophag
inflammatori
protein
mip
eotaxin
regul
upon
express
normal
tcell
express
secret
rant
induc
protein
ip
monokin
induc
gamma
interferon
mig
biosourc
intern
camarillo
ca
nasal
wash
sampl
store
use
thaw
room
temperatur
dilut
prior
analysi
accord
manufactur
instruct
follow
two
hour
incub
spectral
encod
bead
coat
analytespecif
biotinyl
primari
antibodi
sampl
incub
streptavidin
rphycoerythrin
analyz
luminex
multiplex
system
luminex
corpor
austin
tx
data
analyz
star
station
v
softwar
appli
cytometri
system
sacramento
ca
protein
concentr
determin
bradford
microassay
biorad
richmond
ca
bovin
serum
albumin
standard
sigma
chemic
corpor
st
loui
mo
concentr
inflammatori
mediat
report
herein
per
mg
total
protein
correct
differ
nasal
wash
collect
techniqu
chi
squar
test
use
associ
categor
variabl
student
ttest
use
compar
inflammatori
mediat
concentr
differ
group
analys
perform
use
spss
version
identifi
children
posit
nasal
wash
cultur
piv
twelv
patient
exclud
coinfect
anoth
infecti
agent
known
caus
respiratori
ill
respiratori
viru
panel
analysi
nasal
wash
sampl
asymptomat
patient
neg
respiratori
viru
pathogen
season
distribut
piv
infect
viru
type
shown
figur
piv
infect
common
spring
earli
summer
piv
infect
show
peak
spring
fall
median
age
piv
infect
patient
month
rang
wk
yr
fortyon
percent
femal
eighti
patient
one
underli
chronic
medic
condit
thirti
one
patient
born
prematur
week
gestat
age
asthma
reactiv
airway
diseas
chronic
lung
diseas
trisomi
gastroesophag
reflux
diseas
congenit
heart
diseas
cystic
fibrosi
charg
syndrom
primari
hypogammaglobulinemia
common
present
symptom
cough
sign
symptom
acut
respiratori
tract
infect
common
tabl
sixtythre
percent
patient
document
fever
upon
present
patient
present
gastrointestin
complaint
vomit
diarrhea
andor
abdomin
pain
alway
combin
one
respiratori
symptom
sixtyon
patient
treat
outpati
mild
ill
patient
hospit
median
length
stay
day
hospit
group
met
definit
sever
ill
evalu
present
symptom
ill
sever
accord
piv
type
piv
genu
respirovirus
rubulavirus
piv
type
predict
diseas
sever
howev
found
supplement
oxygen
treatment
like
given
patient
respiroviru
infect
compar
rubulaviru
infect
p
surpris
find
gastrointestin
symptom
also
commonli
report
patient
respiroviru
infect
patient
chest
radiograph
perform
abnorm
identifi
radiologist
includ
infiltr
consolid
effac
cardiac
border
almost
half
patient
treat
antibiot
although
none
document
bacteri
infect
tabl
summar
final
clinic
diagnos
patient
piv
type
genu
seventi
patient
upper
respiratori
tract
infect
ltb
sixtyseven
patient
lrti
apnea
describ
patient
three
also
respiratori
symptom
nonrespiratori
diagnos
includ
fever
sourc
patient
dehydr
meningoenceph
two
patient
die
evalu
final
clinic
diagnosi
accord
piv
type
genu
note
ltb
often
caus
piv
singl
case
caus
piv
thirtytwo
thirtyseven
case
bronchiol
occur
infect
respirovirus
case
pneumonia
caus
piv
identifi
patient
infect
piv
four
patient
lower
respiratori
tract
infect
upper
respiratori
tract
infect
one
present
apnea
alon
inflammatori
mediat
assay
nasal
wash
fluid
six
present
higher
concentr
pivinfect
patient
compar
uninfect
control
specif
mig
rant
figur
compar
concentr
inflammatori
mediat
detect
patient
infect
respirovirus
infect
rubulavirs
three
mediat
present
significantli
higher
concentr
among
infect
respirovirus
figur
final
compar
mediat
concentr
among
four
piv
type
consist
find
statist
higher
concentr
patient
infect
piv
figur
evalu
inflammatori
mediat
concentr
relationship
ill
sever
found
nasal
wash
concentr
elev
patient
lrti
compar
uri
figur
similar
comparison
patient
mild
ill
hospit
moder
sever
ill
combin
studi
definit
hospit
reveal
concentr
likewis
higher
latter
group
figur
also
detect
elev
concentr
nasal
wash
sampl
patient
moder
sever
ill
moder
sever
respiroviru
infect
associ
higher
nasal
wash
concentr
compar
mild
respiroviru
infect
similarli
concentr
higher
sampl
patient
diagnos
moder
sever
rubulaviru
infect
compar
mild
rubulaviru
infect
final
observ
higher
nasal
wash
concentr
patient
moder
sever
respiroviru
infect
compar
moder
sever
infect
rubulavirus
figur
studi
describ
clinic
manifest
infect
piv
type
nasal
wash
cytokin
profil
children
acut
piv
infect
median
age
cohort
six
month
male
season
distribut
infect
show
two
peak
one
spring
piv
anoth
fall
piv
expect
piv
common
viru
type
isol
piv
infect
commonli
document
almost
patient
respiratori
symptom
major
fever
larg
proport
also
document
vomit
diarrhea
andor
abdomin
pain
forti
percent
patient
includ
studi
treat
outpati
hospit
requir
oxygen
andor
icu
admiss
two
death
one
piv
one
piv
found
respirovirus
piv
like
caus
lower
respiratori
tract
infect
compar
rubulavirus
piv
piv
associ
pneumonia
common
piv
consist
observ
supplement
oxygen
commonli
use
respiroviru
group
piv
infect
account
case
ltb
cohort
patient
infect
piv
requir
admiss
intens
care
unit
nearli
half
children
includ
studi
receiv
antibiot
therapi
either
emerg
depart
hospit
although
none
document
bacteri
infect
first
publish
studi
present
systemat
evalu
proinflammatori
cytokin
profil
pivinfect
children
examin
relat
diseas
sever
compar
healthi
subject
pivinfect
children
produc
releas
profil
proinflammatori
cytokin
airway
includ
publish
literatur
area
viru
induc
chemokin
express
local
innat
immun
respons
acut
respiratori
viral
infect
focus
cytokin
profil
obtain
form
rsvinfect
children
studi
shown
concentr
correl
rsv
diseas
sever
among
report
henrickson
colleagu
show
higher
concentr
detect
nasopharyng
aspir
collect
wheez
children
rsv
influenza
infect
concentr
correl
ill
sever
gern
colleagu
evalu
nasal
wash
sampl
infant
acut
viral
infect
found
elev
level
infant
rsv
parainfluenza
rhinoviru
infect
find
signific
correl
nasal
concentr
symptom
score
note
piv
viru
type
diseas
sever
evalu
independ
innat
immun
respons
infect
rsv
relat
pneumovirus
also
explor
anim
model
infect
mous
model
rsv
elev
concentr
detect
lung
tissu
follow
viru
challeng
similarli
cotton
rat
model
rsv
challeng
rodent
show
elev
pulmonari
concentr
growthregul
protein
interferon
rodent
specif
pneumoviru
pneumonia
viru
mice
pvm
induc
airway
express
releas
sever
mediat
correl
ill
sever
pulmonari
function
abnorm
includ
human
orthologu
kc
role
piv
pathogenesi
like
given
observ
infect
children
first
concentr
higher
nasal
wash
sampl
pivinfect
patient
compar
control
uninfect
patient
addit
note
concentr
higher
patient
lrti
compar
uri
patient
moder
sever
ill
compar
mild
ill
stratifi
patient
diseas
sever
found
signific
differ
concentr
sever
case
compar
nonsever
case
mechan
piv
induc
host
product
releas
vivo
known
howev
piv
shown
enhanc
releas
airway
epitheli
cell
via
transcript
post
transcript
mean
find
nasal
wash
concentr
higher
patient
sever
piv
diseas
togeth
previous
publish
observ
hydrocortison
reduc
pivinduc
releas
pivinfect
cultur
epitheli
cell
may
offer
biochem
explan
glucocorticoid
effect
reduc
sever
clinic
piv
diseas
children
specif
reduc
chemokin
product
via
glucocorticoid
administr
may
result
diminish
recruit
proinflammatori
leukocyt
result
diminish
inflammatori
respons
symptom
amelior
nasal
wash
concentr
mean
plu
sd
proinflammatori
mediat
compar
result
obtain
patient
uri
compar
lrti
p
b
mild
ill
compar
moder
sever
ill
p
c
mild
respiroviru
mild
lower
respiratori
tract
infect
n
fever
sourc
n
